Microbot Medical Faces Delisting Concerns
Ticker: MBOT · Form: 8-K · Filed: Oct 11, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Oct 11, 2024 |
| Risk Level | high |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $1.00 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rules, corporate-governance
TL;DR
Microbot Medical might get delisted, filing shows.
AI Summary
Microbot Medical Inc. filed an 8-K on October 11, 2024, reporting a notice of delisting or failure to satisfy continued listing rules, a transfer of listing, and shareholder nominations. The filing also includes financial statements and exhibits, with the earliest event reported being October 9, 2024.
Why It Matters
This filing indicates potential issues with Microbot Medical Inc.'s continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — The filing explicitly mentions a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard,' indicating significant risk to the company's exchange listing.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- October 9, 2024 (date) — Earliest event reported
- October 11, 2024 (date) — Filing date
FAQ
What specific listing rule or standard has Microbot Medical Inc. failed to satisfy?
The filing does not specify the exact rule or standard that has not been met, only that a notice has been issued.
What is the nature of the 'Transfer of Listing' mentioned in the filing?
The filing indicates a transfer of listing, but the specific details or destination exchange are not provided in this summary.
Are there any specific shareholder nominations mentioned in the filing?
The filing mentions 'Shareholder Nominations Pursuant to Exchange Act Rule 14a-11' but does not detail the nominees or the context of these nominations.
What are the implications of a 'Notice of Delisting' for Microbot Medical Inc. shareholders?
A delisting notice typically raises concerns about liquidity and the ability to trade the stock, potentially impacting its market value.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on October 9, 2024.
Filing Stats: 1,262 words · 5 min read · ~4 pages · Grade level 14.8 · Accepted 2024-10-11 16:30:20
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
- $1.00 — on the Nasdaq Capital Market was below $1.00 for 30 consecutive business days, from
Filing Documents
- form8-k.htm (8-K) — 47KB
- 0001493152-24-040913.txt ( ) — 221KB
- mbot-20241009.xsd (EX-101.SCH) — 3KB
- mbot-20241009_lab.xml (EX-101.LAB) — 33KB
- mbot-20241009_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: October 11, 2024